Pridopidine, a selective Sigma-1 receptor (S1R) agonist promotes neuroprotection in ALS models

被引：0
|
作者：
Geva, Michal [1 ]
Wang, Shao-Ming [2 ,3 ,5 ]
Wu, Hsiang-En [2 ,4 ]
Ankol, Lior [6 ,7 ]
Ionescu, Ariel [6 ,7 ]
Gradus-Pery, Tal [6 ,7 ]
Gershoni-Emek, Noga [1 ]
Goldberg, Y. Paul [1 ]
Su, Tsung-Ping [2 ]
Perlson, Eran [6 ,7 ]
Hayden, Michael R. [1 ,8 ]
机构：
[1] Prilenia Therapeut, Herzliyya, Israel
[2] Natl Inst Drug Abuse, Natl Inst Hlth, Cellular Pathobiol Sect, Integrat Neurosci Res Branch,Intramural Res Progr, Baltimore, MD USA
[3] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan
[4] China Med Univ, Neurosci & Brain Dis Ctr, Taichung, Taiwan
[5] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan
[6] Sagol Sch Neurosci, Tel Aviv, Israel
[7] Sackler Sch Med, Tel Aviv, Israel
[8] Univ British Columbia, CMMT, Vancouver, BC, Canada
来源：
MUSCLE & NERVE | 2022年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
6
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [1] Pridopidine exerts neuroprotective effects via activation of the Sigma-1 receptor (S1R)
    Hand, Randal
    Ankol, Lior
    Ionescu, Ariel
    Gradus-Pery, Tal
    Wang, Shao-Ming
    Gershoni-Emek, Noga
    Su, Tsung-Ping
    Perlson, Eran
    Geva, Michal
    Goldberg, Y. Paul
    Hayden, Michael R.
    MUSCLE & NERVE, 2023, 68 : S6 - S7
  • [2] Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma
    Michal Geva
    Noga Gershoni-Emek
    Luana Naia
    Philip Ly
    Sandra Mota
    Ana Cristina Rego
    Michael R. Hayden
    Leonard A. Levin
    Scientific Reports, 11
  • [3] Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma
    Geva, Michal
    Gershoni-Emek, Noga
    Naia, Luana
    Ly, Philip
    Mota, Sandra
    Rego, Ana Cristina
    Hayden, Michael R.
    Levin, Leonard A.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Pridopidine, a Highly Selective S1R Agonist for the Treatment of Huntington Disease
    Geva, Michal
    Raymond, Lynn
    Ross, Chris
    Rego, Ana Cristina
    Saudou, Frederic
    Bezprozvanny, Ilya
    Hayden, Michael
    NEUROTHERAPEUTICS, 2019, 16 (04) : 1360 - 1361
  • [5] Sigma-1 receptor (S1R) radioligand uptake in chronic pain
    Hjornevik, T.
    Cipriano, P. W.
    Shen, B.
    Park, J. H.
    Gulaka, P. K.
    McCurdy, C. M.
    Chin, F. T.
    Biswal, S.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2017, 37 : 231 - 232
  • [6] Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases
    Zhemkov, Vladimir
    Geva, Michal
    Hayden, Michael R.
    Bezprozvanny, Ilya
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [7] The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease
    Goldberg, Yigal Paul
    Navon-Perry, Leehee
    Cruz-Herranz, Andres
    Chen, Kelly
    Hecker-Barth, Gabriele
    Spiegel, Katrin
    Cohen, Yael
    Niethammer, Martin
    Tan, Andrew M.
    Schuring, Henk
    Geva, Michal
    Hayden, Michael R.
    CNS DRUGS, 2025, 39 (05) : 485 - 498
  • [8] Visualizing peripheral sigma-1 receptor (S1R) expression in a neuropathic pain model
    Shen, Bin
    Behera, Deepak
    James, Michelle
    Mavlyutov, Timur
    Ruoho, Arnold
    Biswal, Sandip
    Chin, Frederick
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [9] Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists
    Elnaz Khani
    Taher Entezari-Maleki
    Molecular Psychiatry, 2022, 27 : 3562 - 3562
  • [10] Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists
    Khani, Elnaz
    Entezari-Maleki, Taher
    MOLECULAR PSYCHIATRY, 2022, 27 (09) : 3562 - 3562
12345